Skip to main content
    T

    Tenon Medical Inc (TNON)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.25
    -0.08 (-6.37%)

    Market Cap: $3.79M

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Tenon Medical Inc (TNON) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Tenon Medical (TNON) has a market cap of $3.79M. It kept -305.10% of revenue as net income over the last 12 months. It holds $8.27M more cash than debt, 218.17% of its market cap.

    Total Valuation

    Market Cap$3.79M
    Latest price (Nov 17, 2026)$1.25

    Key Dates

    The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 17, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Valuation Ratios

    Sales and book value multiples are 0.3x and 0.3x.

    P/S Ratio0.3x
    Forward P/S0.7x
    P/B Ratio0.3x
    P/TBV Ratio0.5x

    Valuation history and multiples

    Price Statistics

    The stock is down 96.97% over 52 weeks and trades 57.04% below its 50-day average.

    Beta (1Y)1.31
    52-Week Change-96.97%
    1-Month Change-48.98%
    3-Month Change-89.04%
    6-Month Change-94.90%
    Total Return (1Y)-96.97%
    Total Return (3Y CAGR)-86.90%
    Return vs SPY (1Y)-108.40%
    Max Drawdown (1Y)-96.89%
    Max Drawdown (3Y)-99.79%
    Sharpe Ratio (1Y)-1.89
    Correlation with SPY (1Y)0.10
    50-Day Average$2.91
    200-Day Average$15.22
    52-Week Range$1.30 to $40.95
    RSI (14 Days)25.7
    Average Volume (20 Days)122.82K

    Price chart

    Financial Position

    Current assets cover 2.93x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.93x
    Quick Ratio2.70x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -184.39% and return on assets is -104.93% over the last 12 months.

    Return on Equity (ROE)-184.39%
    Return on Assets (ROA)-104.93%
    Return on Capital Employed (ROCE)-124.34%
    Asset Turnover0.42x
    Inventory Turnover2.22x
    Receivables Turnover3.05x
    Cash Conversion Cycle157 days

    Scores

    TNON has an Altman Z-Score of -10.36, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-10.36
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $5.57M over the last 12 months is up 72.32% from the 12 months before.

    Revenue$5.57M
    Revenue Growth (YoY)+72.32%
    Gross Profit$3.73M
    Operating Income-$12.59M
    Pretax Income-$17.00M
    Net Income-$17.00M
    EBIT-$15.38M
    Reported EPS (TTM)-$28.81

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 56.91% of the $16.20M in total assets.

    Cash and Equivalents$8.27M
    Total Debt$0
    Net Cash$8.27M
    Net Cash Per Share$6.72
    Working Capital$7.39M
    Shareholder Equity$9.22M
    Book Value Per Share$4.99
    Tangible Book Value$6.37M
    Tangible Book Per Share$2.68
    Total Assets$16.20M
    Total Liabilities$6.98M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $428.00K of capital spending, operating cash flow left -$10.76M of free cash flow.

    Operating Cash Flow-$10.33M
    Capital Expenditures$428.00K
    Free Cash Flow-$10.76M
    FCF Per Share-$4.00
    Depreciation and Amortization$2.34M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -225.90%.

    Gross Margin66.88%
    Operating Margin-225.90%
    Pretax Margin-305.10%
    Net Margin-305.10%
    EBIT Margin-276.00%
    FCF Margin-193.11%
    Gross Margin (5Y Average)25.45%

    Growth

    Revenue grew 78.71% a year over 3 years.

    Revenue Growth (3Y CAGR)+78.71%
    Revenue Growth (5Y CAGR)+145.95%

    Revenue and profit by year

    Dividends and Yields

    TNON does not pay a dividend. Its free cash flow yield is -699.14%.

    FCF Yield-699.14%
    Buyback Yield-691.73%
    Shareholder Yield-691.73%

    Stock Splits

    The last split was a 1-for-35 reverse split on Aug 10, 2026.

    Last Split DateAug 10, 2026
    Split TypeReverse split
    Split Ratio1:35

    Peer Position

    Against 6 similar companies, TNON has the 6th highest P/S.

    P/S Ratio0.3x vs 0.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)+72.32% vs +18.57% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 49.95% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+49.95%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About TNON

    What is TNON's market cap?

    Tenon Medical has a market cap of $3.79M.

    How many shares of TNON are outstanding?

    Tenon Medical has 1.23M shares outstanding.

    Does TNON pay a dividend?

    No. Tenon Medical does not pay a dividend.

    How much debt does TNON have?

    Tenon Medical has $0 of total debt and $8.27M of cash and equivalents, a net cash position of $8.27M.